Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Butterfly Equity, LP on the transaction. Butterfly announced the separation of its portfolio company Bolthouse Farms into two standalone entities; Bolthouse Fresh...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Butterfly in the transaction. Butterfly, a Los Angeles-based private equity firm specializing in the food sector, announced its recently closed sophomore fund. Nearly...
You must be a Standard 1 Year member to access this content.
